Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease
Annals of Internal Medicine · 2026-03 · 179 (3) · 340-352
DOI: 10.7326/annals-25-01262 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Internal Medicine, 2026-03. Verfasst von Frederik P B Kristensen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark (F.P.B.K., …. Hauptthemen laut MEDLINE: Diabetic Foot, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark (F.P.B.K., H.T.S., R.W.T.).
- Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, and Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmar…
- Department of Neurology, University of Michigan, Ann Arbor, Michigan (B.C.C.).
- Steno Diabetes Center Odense, Odense University Hospital, and Department of Clinical Research, University of Southern Denmark, Odense, Denmark (J.S.N.).
- Department of Neurology, Aarhus University Hospital, Aarhus, Denmark (H.A.).
ORCID-Profile: Frederik P B Kristensen, Diana H Christensen, Brian C Callaghan, Jens S Nielsen, Henrik T Sørensen, Reimar W Thomsen
Zitieren
APA
Kristensen, F. P. B., Christensen, D. H., Callaghan, B. C., Nielsen, J. S., Andersen, H., Sørensen, H. T., & Thomsen, R. W. (2026). Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease. Annals of Internal Medicine, 179(3), 340-352. https://doi.org/10.7326/annals-25-01262
Vancouver
Kristensen FPB, Christensen DH, Callaghan BC, Nielsen JS, Andersen H, Sørensen HT, et al. Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease. Annals of Internal Medicine. 2026;179(3):340-352. doi:10.7326/annals-25-01262
BibTeX
@article{Kristensen2026,
author = {Kristensen, Frederik P B and Christensen, Diana H and Callaghan, Brian C and Nielsen, Jens S and Andersen, Henning and Sørensen, Henrik T and Thomsen, Reimar W},
title = {Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease},
journal = {Annals of Internal Medicine},
year = {2026},
volume = {179},
number = {3},
pages = {340--352},
doi = {10.7326/annals-25-01262}
}
EUVIMED